MITF from control of pigmentation to melanoma risk
MITF 从控制色素沉着到黑色素瘤风险
基本信息
- 批准号:10828041
- 负责人:
- 金额:$ 9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-16 至 2025-02-28
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Abstract
Human skin phototypes are routinely described in a gradient of 1 (redhaired) to 6 (dark constitutive pigment)
which correlates with UV sensitivity and risk of melanoma, Parallel to this gradient is the increase of nevi (moles)
from darker to lighter phototypes, a gradient which abruptly drops at phototype 1 (redhaired) where visible nevi
are unexpectedly rare, We hypothesized, and verified in murine models, that BRAFveooE_ induced nevi in
redhaired mice are "invisible" but actually significantly more abundant compared to genetically matched black
mice, They are clinically inapparent due to lack of dark eumelanin, but are easily identified via fluorescence
tagging, and associated with profoundly elevated spontaneous melanoma transformation and UVA-induced
melanoma risk in redhaired mice, This melanoma risk was traced to red pigment because "albino-redhaired"
mice lack all pigment and are protected from either spontaneous (previously published), UVA-induced, or
peroxide-induced melanoma, Spontaneous and UVA-induced "invisible" nevi and melanoma-genesis are
proposed for study in Aims 1 and 2 for NRASQ61
R pigment models, the 2"d most common human nevus and
melanoma oncogene, to complement our extensive unpublished data for BRAFveooE, Several small molecule
approaches will be tested to potentially mitigate pheomelanin-induced melanoma risk including induction of dark
eumelanin synthesis, One such example was already seen to "reveal" visible lesions in the "invisible" nevusbearing
redhaired mice, In addition, the fluorescent nevi, engineered into isogenic pigment backgrounds, will be
flow-sorted from skin and transcriptomically scrutinized to mechanistically dissect the pathways and genes
(including redox) that mediate the elevated melanoma risk among fair skinned individuals, Only a minority of
melanomas arise from pre-existing nevi, so we use our models to examine both nevi and overall melanoma risk,
We also discovered that the Parkinson's Disease therapy L-Dopa significantly elevates pheomelanin synthesis
in redheads, Separate from being a dopamine precursor, L-Dopa is coincidentally a chemical intermediate in
melanin biosynthesis, Parkinson's Disease and melanoma have long been associated with one another, but
lacking a mechanistic explanation, We observed that low dose L-Dopa significantly elevates melanoma risk in
BRAFveooE redhaired, but not in albino-red mouse models (which cannot make pheomelanin or eumelanin), Aim
3 will test L-Dopa's melanoma causality in NRAS061R redhaired models and whether topical skin darkening may
modify the enhanced melanoma risk already observed for BRAFveooE, Finally, Aim 4 will examine the hypothesis
that M ITF regulates expression of an anti-oxidant pathway which includes enzymes controlling regeneration of
reduced NADPH and glutathione-key factors buffering melanocyte oxidative stress, One such enzyme, the
mitochondrial enzyme NNT, was recently shown to modulate melanocyte redox and melanosome differentiation,
We will test evidence that NNT is a transcriptional target of M ITF and functionally scrutinize a newly identified
sequence variant in NNT, nominated by NCI collaborators as a candidate familial melanoma gene in humans.
摘要
人类皮肤光型通常描述为1(红发)至6(深色组成色素)的梯度
与紫外线敏感度和黑色素瘤风险相关,与此梯度平行的是痣(痣)的增加
从较暗到较亮的光型,在光型1(红发)处突然下降的梯度,
出乎意料的罕见,我们假设,并在小鼠模型中证实,BRAFveooE_诱导痣,
红毛老鼠是“看不见的”,但实际上比基因匹配的黑毛老鼠数量要多得多。
由于缺乏深色真黑素,它们在临床上不明显,但很容易通过荧光识别
标签,并与高度升高的自发性黑色素瘤转化和UVA诱导的
这种黑色素瘤的风险被追溯到红色素,因为“白化红毛”
小鼠缺乏所有的色素,并受到保护,无论是自发的(以前发表),UVA诱导,或
过氧化物诱导的黑色素瘤、自发性和UVA诱导的“隐形”痣和黑色素瘤发生是
建议在NRASQ 61的目标1和2中进行研究
R色素模型,2D最常见的人类痣和
黑色素瘤癌基因,以补充我们广泛的未发表的数据BRAFveooE,几个小分子
将测试可能减轻褐黑素诱导的黑色素瘤风险的方法,
真黑素的合成,一个这样的例子已经被认为是“揭示”可见病变的“不可见的”痣
此外,荧光痣,工程到同基因色素背景,将是
从皮肤上进行流式分选,并进行转录组学检查,
(包括氧化还原),介导皮肤白皙个体中黑色素瘤风险升高,只有少数
黑色素瘤由先前存在的痣引起,因此我们使用我们的模型来检查痣和整体黑色素瘤风险,
我们还发现,帕金森病治疗L-多巴显着提高了褐黑素的合成
在红头发的人中,左旋多巴与多巴胺的前体不同,它碰巧是一种化学中间体,
黑色素生物合成、帕金森病和黑色素瘤长期以来一直相互关联,但
由于缺乏机制上的解释,我们观察到低剂量的左旋多巴显著提高了黑色素瘤的风险,
BRAFveooE红毛,但在白化红小鼠模型(不能产生褐黑素或真黑素)中没有,Aim
3将在NRAS 061 R红发模型中测试L-多巴的黑色素瘤因果关系,以及局部皮肤变黑是否可能
修改已经观察到的BRAFveooE增加的黑色素瘤风险,最后,目标4将检验假设
MITF调节抗氧化途径的表达,该途径包括控制再生的酶,
还原型NADPH和谷胱甘肽-缓冲黑素细胞氧化应激的关键因子,
线粒体酶NNT,最近显示调节黑素细胞氧化还原和黑素体分化,
我们将测试NNT是M ITF的转录靶点的证据,并从功能上仔细检查新发现的
NNT中的一个序列变异,被NCI合作者提名为人类家族性黑色素瘤的候选基因。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID E FISHER其他文献
DAVID E FISHER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID E FISHER', 18)}}的其他基金
A druggable dependency in low-MITF/high-AXL melanoma: preclinical efficacy and mechanism of action in a key treatment-resistant subclass.
低 MITF/高 AXL 黑色素瘤的药物依赖性:关键耐药亚类的临床前疗效和作用机制。
- 批准号:
10331800 - 财政年份:2018
- 资助金额:
$ 9万 - 项目类别:
Preclinical models and therapeutic strategies for treatment of giant congenital melanocytic nevi
先天性巨大黑素细胞痣的临床前模型及治疗策略
- 批准号:
9753925 - 财政年份:2017
- 资助金额:
$ 9万 - 项目类别:
Preclinical models and therapeutic strategies for treatment of giant congenital melanocytic nevi
先天性巨大黑素细胞痣的临床前模型及治疗策略
- 批准号:
9376481 - 财政年份:2017
- 资助金额:
$ 9万 - 项目类别:
Preclinical models and therapeutic strategies for treatment of giant congenital melanocytic nevi
先天性巨大黑素细胞痣的临床前模型及治疗策略
- 批准号:
10245261 - 财政年份:2017
- 资助金额:
$ 9万 - 项目类别:
Therapeutic strategies for treatment of giant congenital melanocytic nevi
巨大先天性黑素细胞痣的治疗策略
- 批准号:
10570507 - 财政年份:2017
- 资助金额:
$ 9万 - 项目类别:
Preclinical models and therapeutic strategies for treatment of giant congenital melanocytic nevi
先天性巨大黑素细胞痣的临床前模型及治疗策略
- 批准号:
9977915 - 财政年份:2017
- 资助金额:
$ 9万 - 项目类别:
Development of next-generation cancer functional diagnostics
下一代癌症功能诊断的开发
- 批准号:
8492572 - 财政年份:2013
- 资助金额:
$ 9万 - 项目类别:
Project 1: Remodeling Chromatin and the Tumor Microenvironment: Direct Oncogenesis and Therapeutic Targeting
项目 1:重塑染色质和肿瘤微环境:直接肿瘤发生和治疗靶向
- 批准号:
10443720 - 财政年份:2013
- 资助金额:
$ 9万 - 项目类别:
Targetable epigenetic and transcriptional mechanisms in melanoma that shape the microenvironment
黑色素瘤中塑造微环境的靶向表观遗传和转录机制
- 批准号:
9792731 - 财政年份:2013
- 资助金额:
$ 9万 - 项目类别:
相似国自然基金
The Heterogenous Impact of Monetary Policy on Firms' Risk and Fundamentals
- 批准号:
- 批准年份:2024
- 资助金额:万元
- 项目类别:外国学者研究基金项目
基于移动健康技术干预动脉粥样硬化性心血管疾病高危人群的随机对照现场试验:The ASCVD Risk Intervention Trial
- 批准号:81973152
- 批准年份:2019
- 资助金额:54.0 万元
- 项目类别:面上项目
基于时间序列间分位相依性(quantile dependence)的风险值(Value-at-Risk)预测模型研究
- 批准号:71903144
- 批准年份:2019
- 资助金额:17.0 万元
- 项目类别:青年科学基金项目
RISK通路在胃泌素介导的心脏缺血再灌注损伤保护中的作用研究
- 批准号:81800239
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
异氟烷基于TLR4/RISK/NF-κB调控糖尿病缺血性脑卒中后NLRP3炎症小体形成的机制研究
- 批准号:81771232
- 批准年份:2017
- 资助金额:54.0 万元
- 项目类别:面上项目
Notch1与RISK/SAFE/HIF-1α信号通路整合在I-postC保护中的作用及其机制
- 批准号:81260024
- 批准年份:2012
- 资助金额:50.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Optimization of a personalized skin cancer risk intervention for at-risk young adults
针对高危年轻人的个性化皮肤癌风险干预措施的优化
- 批准号:
10582944 - 财政年份:2023
- 资助金额:
$ 9万 - 项目类别:
Dissecting GWAS Identified Risk Variants in Parkinson's Disease – Functional Role of GPNMB in the Pathogenesis of PD
剖析 GWAS 确定的帕金森病风险变异 — GPNMB 在帕金森病发病机制中的功能作用
- 批准号:
10680117 - 财政年份:2023
- 资助金额:
$ 9万 - 项目类别:
Molecular Phenotyping and Image-Guidance for Surgical Treatment of High-Risk Prostate Cancer Using Ultrasmall Silica Nanoparticles
使用超小二氧化硅纳米粒子进行高风险前列腺癌手术治疗的分子表型分析和图像引导
- 批准号:
10908927 - 财政年份:2023
- 资助金额:
$ 9万 - 项目类别:
Skin Cancer Risks and Risk Prediction in Patients with Actinic Keratosis
光化性角化病患者的皮肤癌风险和风险预测
- 批准号:
10448977 - 财政年份:2022
- 资助金额:
$ 9万 - 项目类别:
Quantitative assessment of pre-metastatic immune subversion as a risk factor for melanoma relapse
转移前免疫颠覆作为黑色素瘤复发危险因素的定量评估
- 批准号:
10310757 - 财政年份:2022
- 资助金额:
$ 9万 - 项目类别:
Skin Cancer Risks and Risk Prediction in Patients with Actinic Keratosis
光化性角化病患者的皮肤癌风险和风险预测
- 批准号:
10610895 - 财政年份:2022
- 资助金额:
$ 9万 - 项目类别:
Quantitative assessment of pre-metastatic immune subversion as a risk factor for melanoma relapse
转移前免疫颠覆作为黑色素瘤复发危险因素的定量评估
- 批准号:
10683924 - 财政年份:2022
- 资助金额:
$ 9万 - 项目类别:
The role of UTX in Epidermal Homeostasis, Carcinogenesis, and Sex Mediated Risk of Cutaneous Squamous Cell Carcinoma
UTX 在表皮稳态、癌变和性介导的皮肤鳞状细胞癌风险中的作用
- 批准号:
10311627 - 财政年份:2021
- 资助金额:
$ 9万 - 项目类别:
The role of UTX in Epidermal Homeostasis, Carcinogenesis, and Sex Mediated Risk of Cutaneous Squamous Cell Carcinoma
UTX 在表皮稳态、癌变和性介导的皮肤鳞状细胞癌风险中的作用
- 批准号:
10457290 - 财政年份:2021
- 资助金额:
$ 9万 - 项目类别:
The role of UTX in Epidermal Homeostasis, Carcinogenesis, and Sex Mediated Risk of Cutaneous Squamous Cell Carcinoma
UTX 在表皮稳态、癌变和性介导的皮肤鳞状细胞癌风险中的作用
- 批准号:
10669185 - 财政年份:2021
- 资助金额:
$ 9万 - 项目类别:














{{item.name}}会员




